Science Explorer Back to mapMap

Most cited papers from Adenosine Therapeutics (United States)

Adenosine Therapeutics (United States)

What are the most cited papers from Adenosine Therapeutics (United States)?

The most cited paper from Adenosine Therapeutics (United States) is "A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells" (Courtney M. Lappas, Jayson M. Rieger, Joel M Linden, 2005), with 386 citations. Next come "Neuroinflammation in Alzheimer’s Disease" (323) and "Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease" (142).

Showing 45 of 45 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells Courtney M. Lappas, Jayson M. Rieger, Joel M Linden · The Journal of Immunology Open access 2005 386
2 Neuroinflammation in Alzheimer’s Disease Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária E. Čarná et al. · Biomedicines Open access 7 May 2021 323
3 Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease Shreaya Chakroborty, Clark A. Briggs, Megan B. Miller et al. · PLoS ONE Open access 21 Dec 2012 142
4 The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells Jeffrey M. Wilson, William G. Ross, Oma N. Agbai et al. · The Journal of Immunology Open access Apr 2009 136
5 Links Between Insulin Resistance, Adenosine A2B Receptors, and Inflammatory Markers in Mice and Humans Robert A. Figler, Guoquan Wang, Susseela Srinivasan et al. · Diabetes Open access 21 Jan 2011 120
6 T-type calcium channels blockers as new tools in cancer therapies Barbara Dziegielewska, Lloyd S. Gray, Jaroslaw Dziegielewski · Pflügers Archiv - European Journal of Physiology 21 Jan 2014 111
7 A2A Adenosine Receptors on Bone Marrow-Derived Cells Protect Liver from Ischemia-Reperfusion Injury Yuan‐Ji Day, Yuesheng Li, Jayson M. Rieger et al. · The Journal of Immunology Apr 2005 95
8 Inhibition of T-type calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells Nicholas C.K. Valerie, Barbara Dziegielewska, Amol S. Hosing et al. · Biochemical Pharmacology 31 Dec 2012 93
9 A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence Mohammad Samiul Alam, Courtney C. Kurtz, Jeffrey M. Wilson et al. · Mucosal Immunology Open access 4 Mar 2009 78
10 RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord David G. Brohawn, Laura C. O’Brien, James P. Bennett · PLoS ONE Open access 3 Aug 2016 76
11 Effect of Novel A2AAdenosine Receptor Agonist ATL 313 onClostridium difficileToxin A-Induced Murine Ileal Enteritis Ingrid Chaves Cavalcante, M. V. Castro, A. R. F. Barreto et al. · Infection and Immunity 18 Apr 2006 74
12 Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels Yugesh Kharel, Emily A. Morris, Molly D. Congdon et al. · Journal of Pharmacology and Experimental Therapeutics Open access 5 Aug 2015 67
13 Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model Stephen Thomas Keir, Henry S. Friedman, David A. Reardon et al. · Journal of Neuro-Oncology 19 Oct 2012 62
14 Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow–derived cells or deletion of the A2A receptor on non-bone marrow–derived cells Y. Li, Rod J. Oskouian, Yuan‐Ji Day et al. · Neuroscience 2006 53
15 Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases IsaacG Onyango, JamesP Bennett, Gorazd Bernard Stokin · Neural Regeneration Research Open access 2021 47
16 RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer’s Disease and Parkinson’s Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia James P. Bennett, Paula M. Keeney, David G. Brohawn · Frontiers in Neuroscience Open access 28 Mar 2019 42
17 Alzheimer’s and Parkinson’s brain tissues have reduced expression of genes for mtDNA OXPHOS Proteins, mitobiogenesis regulator PGC-1α protein and mtRNA stabilizing protein LRPPRC (LRP130) James P. Bennett, Paula M. Keeney · Mitochondrion Jun 2020 37
18 Adenosine A2A Analogue Improves Neurologic Outcome after Spinal Cord Trauma in the Rabbit David C. Cassada, Curtis G. Tribble, Jeffrey S. Young et al. · The Journal of Trauma: Injury, Infection, and Critical Care Aug 2002 35
19 In Vivo Molecular Imaging Biomarkers: Clinical Pharmacology’s new “PET”? R. Nutt, L J Vento, Maya Ridinger · Clinical Pharmacology & Therapeutics 15 May 2007 28
20 Sphingosine kinase inhibitors: a review of patent literature (2006-2015) Kevin R. Lynch, Steven B. Thorpe, Webster L. Santos · Expert Opinion on Therapeutic Patents Open access 19 Aug 2016 27
21 Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer’s Disease James P. Bennett, Jeffrey Murray Burns, Paul Welch et al. · Journal of Alzheimer s Disease Open access 11 Dec 2015 27
22 Repurposing and Rescuing of Mibefradil, an Antihypertensive, for Cancer: A Case Study Andrew J. Krouse, Lloyd A. Gray, Timothy L. Macdonald et al. · Assay and Drug Development Technologies Dec 2015 27
23 Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures James P. Bennett, Isaac G. Onyango · Biomedicines Open access 22 Feb 2021 26
24 Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosis James P. Bennett, Laura C. O’Brien, David G. Brohawn · Biochemical Pharmacology 4 Aug 2016 24
25 Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease Isaac G. Onyango, James P. Bennett, Gorazd Bernard Stokin · Current Alzheimer Research Open access Sep 2021 22
26 Exploiting MCF-7 Cells’ Calcium Dependence with Interlaced Therapy Jonathan E. Pottle, Chengrong Sun, Lloyd S. Gray et al. · Journal of Cancer Therapy Open access 2013 21
27 Platelet P2 receptors: from curiosity to clinical targets Noel J. Cusack, Susanna M.O. Hourani · Journal of the Autonomic Nervous System Jul 2000 21
28 RNA-seq analyses reveal that cervical spinal cords and anterior motor neurons from amyotrophic lateral sclerosis subjects show reduced expression of mitochondrial DNA-encoded respiratory genes, and rhTFAM may correct this respiratory deficiency Amy C. Ladd, David G. Brohawn, Ravindar R. Thomas et al. · Brain Research 13 May 2017 20
29 Pharmacology of 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470), a novel, short-acting adenosine A2A receptor agonist that produces selective coronary vasodilation Pauline L. Martin, Richard J. Barrett, Joel M Linden et al. · Drug Development Research Apr 1997 19
30 RNA-Sequencing Reveals Similarities and Differences in Gene Expression in Vulnerable Brain Tissues of Alzheimer’s and Parkinson’s Diseases James P. Bennett, Paula M. Keeney · Journal of Alzheimer s Disease Reports Open access 6 Mar 2018 18
31 Effects of 2-methylthioadenosine 5?-?,?-methylenetriphosphonate and 2-ethylthioadenosine 5?-monophosphate on human platelet activation induced by adenosine 5?-diphosphate Susanna M.O. Hourani, Laurence A. Welford, Noel J. Cusack · Drug Development Research May 1996 17
32 Early adenosine receptor activation ameliorates spinal cord reperfusion injury Thomas Brett Reece, Curtis G. Tribble, David O. Okonkwo et al. · Journal of Cardiovascular Medicine Open access Apr 2008 17
33 Alzheimer’s Disease Frontal Cortex Mitochondria Show a Loss of Individual Respiratory Proteins but Preservation of Respiratory Supercomplexes Paula M. Kenney, James P. Bennett · International Journal of Alzheimer s Disease Open access 5 Mar 2019 12
34 Micro RNA’s (mirna’s) may help explain expression of multiple genes in Alzheimer’s Frontal Cortex James P. Bennett, Paula M. Keeney · Journal of Systems and Integrative Neuroscience Open access 2017 9
35 Medical hypothesis: Neurodegenerative diseases arise from oxidative damage to electron tunneling proteins in mitochondria James P. Bennett · Medical Hypotheses Open access 28 Mar 2019 8
36 Pharmacology and toxicology of the A2A-adenosine receptor agonist 2- [(cyclohexylmethylene)hydrazino]adenosine (MRE-0470) in the rat Pauline L. Martin, Richard J. Barrett, Alex M. Sykes et al. · Drug Development Research Oct 1997 5
37 Nutraceuticals: Miracle or Meme? Maya Ridinger · Clinical Pharmacology & Therapeutics 13 Sep 2007 5
38 Laser-captured spinal cord motorneurons from ALS subjects show increased gene expression in vacuolar ATPase networks Amy C. Ladd, David G. Brohawn, James P. Bennett · Journal of Systems and Integrative Neuroscience Open access 2017 3
39 Conjugation of nitrated acetaminophen to Der p1 amplifies peripheral blood monocyte response to Der p1 Ryan G. Thomas, Brenda M. Rivera Reyes, Benjamin M Gaston et al. · PLoS ONE Open access 11 Dec 2017 3
40 Presentation of ichthyosis after substrate reduction therapy in Gaucher type 1 Jack Herbster, Carlos Enrique Prada, Carly A. Rasmussen et al. · American Journal of Medical Genetics Part A Open access 5 Aug 2024 1
41 A Spotlight on Microneurotrophins: The Future of Amyotrophic Lateral Sclerosis Treatment? James P. Bennett · Neurodegenerative Disease Management Open access Jun 2015 1
42 « ENTRE DETERMINISME PSYCHOLOGIQUE ET IMPERATIF DE JUSTICE : ANALYSE CRITIQUE DE L'EFFICACITE PREVENTIVE EN DROIT PENAL INTERNATIONAL » Paulin Nyengo Olonge · Zenodo (CERN European Organization for Nuclear Research) PreprintOpen access 20 Apr 2026 0
43 Regulation of T-Type Ca2+ Channels in Cancer Cell Cycle Jonathan E. Pottle, Lloyd S. Gray Book chapter 18 Nov 2014 0
44 80. Long-duration reversal of neuropathic pain via sustained release of spinal interleukin-10 is mediated by adenosine 2A receptor activation Lisa Carole Loram, Evan M. Sloane, Jackie Harrison et al. · Brain Behavior and Immunity Jul 2009 0
45 Is the Dx for Welfare Rx? Maya Ridinger · Clinical Pharmacology & Therapeutics 16 Apr 2007 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.